Stockreport

Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF Reported positive Phase 2b results in symptomatic patients with moderate to severe COPD with nebulized ensifentrine Reported positive efficacy and safety with single do [Read more]